Global Humanized Mouse and Rat Model Market Forecast to 2022


Reading time ( words)

The humanized mouse models market is projected to reach $128.9 Million by 2022 from $80.3 Million in 2017, at a CAGR of 9.9% during the forecast period. The humanized rat models market is expected to reach $8.9 Million by 2022 from $5.9 Million in 2017, at a CAGR of 8.4% during the forecast period.

The key factors boosting market growth are increasing number of R&D activities in pharmaceutical and biotechnology companies, increasing number of research activities involving humanized models, continuous support in the form of investments and grants from the government and private sectors, and growing demand for personalized medicine.

By type, the humanized mouse models market is segmented into genetic and cell-based humanized mouse models. In 2017, the genetic models segment accounted for the largest share of the humanized mouse models market. The factors contributing to the large share of this segment include its widespread use in compound analysis and biological efficacy & safety testing.

Furthermore, the cell-based humanized mouse models is categorized into CD34, PBMC, and BLT humanized mouse models. In 2017, the CD34 models segment accounted for the largest share of the cell-based humanized mouse models market and is expected to register the highest growth rate during the forecast period.

The major factors driving the growth of this market are usage of CD34 mouse models in in-vivo platforms for analyzing the safety and effectiveness of potential new drugs that can modulate the immune system. They are used for long-term studies in the fields of immuno-oncology, infectious disease, and graft versus host disease. Thus, the growing application areas of CD34 models are expected to trigger the demand for these models in the coming years.

By application, the humanized mouse models market is segmented into oncology, immunology and infectious diseases, neuroscience, hematopoiesis, toxicology, and other applications. The oncology segment is estimated to grow at the highest CAGR owing to factors such as increasing research activities and growing funding from various governments to carry out research studies on cancer.

By end user, the humanized mouse models market is segmented into pharmaceutical & biotechnology companies, contract research organizations (CROs), and academic & research institutions. The pharmaceutical & biotechnology companies segment accounted for the largest share of the humanized mouse models market in 2017. However, the contract research organizations (CROs) segment of the market is projected to grow at the highest CAGR during the forecast period. Increasing number of pharmaceutical companies outsourcing their preclinical studies to contract research organizations (CROs) is one of the factors contributing to the growth of this segment.

Share


Suggested Items

Telecom (Compute and Storage) Infrastructure Market to Reach $16.35B in 2022

09/03/2018 | IDC
A new forecast from IDC sizes the market for compute and storage infrastructure for Telecoms at nearly $10.81 billion in 2017. However, as Telecoms aggressively build out their infrastructure, IDC projects this market to see a healthy five-year compound annual growth rate (CAGR) of 6.2% with purchases totaling $16.35 billion in 2022.

What’s Coming in 3D Printing Technology in 2018

12/27/2017 | Cullen Hilkene, 3Diligent
First, the arrival of extrusion metal printing. Today's extrusion printers are the most prevalent and, arguably, user-friendly 3D Printers in the market. Now, after years of there being zero metal extrusion printers, there will be two in the new year from Desktop Metal and Markforged. These technologies promise new materials and a higher degree of user friendliness for metal printing.

Global LED Market Expected to Record a CAGR of close to 17% until 2020

05/26/2016 | Business Wire
This research report titled ‘Global LED Market 2016-2020’ provides an in-depth analysis of market growth in terms of revenue and emerging market trends. The market size is calculated on the basis of revenue generated from four segments, including general lighting, backlighting, automotive lighting, and others.



Copyright © 2018 I-Connect007. All rights reserved.